Skip to main content
Top
Published in: European Radiology 11/2008

01-11-2008 | Gastrointestinal

Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy

Authors: Johannes Sailer, Philipp Peloschek, Walter Reinisch, Harald Vogelsang, Karl Turetschek, Wolfgang Schima

Published in: European Radiology | Issue 11/2008

Login to get access

Abstract

The purpose of this study was to assess the accuracy of MR enteroclysis in patients with Crohn’s disease recurrence after ileocolic resection and to establish an MR scoring sytem. MR enteroclysis and endoscopy were performed in 30 patients with suspected Crohn’s disease recurrence after ileocolic resection. Findings were evaluated by three radiologists, using an MR score based on image quality, contrast enhancement, and mural and extramural bowel-wall changes: MR0 (no abnormal features), MR1 (minimal mucosal changes), MR2 (diffuse aphtoid ileitis, moderate recurrence), and MR3 (severe recurrence with trans- and extramural changes). The endoscopic Rutgeerts score defines changes at the ileum on a scale from I0 to I4. In 3/30 (10%) patients, evaluation was not possible. The mean overall image quality was rated as 1.7 (kappa 0.78). Comparing MR and Rutgeerts score, the mean observer agreement for the total score rating was 77.8% (kappa 0.67). When comparing only scores below or above MR2—the threshold indicative of the necessity of medical treatment—there was a total agreement of 95.1% (kappa 0.84). MR enteroclysis allows assessment of Crohn’s disease recurrence after ileocolic resection. The MR score is reproducible and shows high agreement with the approved endoscopic Rutgeerts score.
Literature
1.
go back to reference Przemioslo RT, Ciclitira PJ (1995) Pathogenesis of Crohn’s disease. Q J Med 88:525–527 Przemioslo RT, Ciclitira PJ (1995) Pathogenesis of Crohn’s disease. Q J Med 88:525–527
2.
go back to reference Daperno M, D’Haens G, Van Assche G et al (2004) Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 60:505–512PubMedCrossRef Daperno M, D’Haens G, Van Assche G et al (2004) Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 60:505–512PubMedCrossRef
3.
go back to reference Becker JM (1999) Surgical therapy for ulcerative colitis and Crohn’s disease. Gastroenterol Clin North Am 28:371–390PubMedCrossRef Becker JM (1999) Surgical therapy for ulcerative colitis and Crohn’s disease. Gastroenterol Clin North Am 28:371–390PubMedCrossRef
4.
go back to reference D’Haens GR, Geboes K, Peeters M, Baert F, Penninck F, Rutgeerts P (1998) Early lesions of recurrent Crohn’s disease caused by infusion of intestinal excluded ileum. Gastroenterology 114:262–267PubMedCrossRef D’Haens GR, Geboes K, Peeters M, Baert F, Penninck F, Rutgeerts P (1998) Early lesions of recurrent Crohn’s disease caused by infusion of intestinal excluded ileum. Gastroenterology 114:262–267PubMedCrossRef
5.
go back to reference Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963PubMed Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963PubMed
6.
go back to reference Ollendorf DA, Massarotti E, Birbara C, Burgess SM (2005) Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis. J Manag Care Pharm 11:383–393PubMed Ollendorf DA, Massarotti E, Birbara C, Burgess SM (2005) Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis. J Manag Care Pharm 11:383–393PubMed
7.
go back to reference Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ (2005) Sargramostim in Crohn’s disease study group. Sargramostim for active Crohn’s disease. N Engl J Med 352:2193–2201PubMedCrossRef Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ (2005) Sargramostim in Crohn’s disease study group. Sargramostim for active Crohn’s disease. N Engl J Med 352:2193–2201PubMedCrossRef
8.
go back to reference Rutgeerts P, Van Assche G, Vermeire S et al (2005) Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 128:856–861PubMedCrossRef Rutgeerts P, Van Assche G, Vermeire S et al (2005) Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 128:856–861PubMedCrossRef
9.
go back to reference Prassopoulos P, Papanikolaou N, Grammatikakis J, Rousomoustakaki M, Maris T, Gourtsoyiannis N (2001) MR enteroclysis imaging of Crohn disease. Radiographics 21:161–172 Prassopoulos P, Papanikolaou N, Grammatikakis J, Rousomoustakaki M, Maris T, Gourtsoyiannis N (2001) MR enteroclysis imaging of Crohn disease. Radiographics 21:161–172
10.
go back to reference Masselli G, Casciani E, Polettini E et al (2006) Assessment of Crohn’s disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis. Eur Radiol 16:2817–2827PubMedCrossRef Masselli G, Casciani E, Polettini E et al (2006) Assessment of Crohn’s disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis. Eur Radiol 16:2817–2827PubMedCrossRef
11.
go back to reference Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Prassopoulos P (2002) MR enteroclysis: technical considerations and clinical applications. Eur Radiol 12:2651–2658PubMed Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Prassopoulos P (2002) MR enteroclysis: technical considerations and clinical applications. Eur Radiol 12:2651–2658PubMed
12.
go back to reference Masselli G, Brizi GM, Parrella A, Minordi LM, Vecchioli A, Marano P (2004) Crohn disease: magnetic resonance enteroclysis. Abdom Imaging 29:326–334PubMedCrossRef Masselli G, Brizi GM, Parrella A, Minordi LM, Vecchioli A, Marano P (2004) Crohn disease: magnetic resonance enteroclysis. Abdom Imaging 29:326–334PubMedCrossRef
13.
go back to reference Maccioni F, Bruni A, Viscido A et al (2006) MR imaging in patients with Crohn’s disease: value of T2- versus T1-weighted gadolinium- enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238:517–530PubMedCrossRef Maccioni F, Bruni A, Viscido A et al (2006) MR imaging in patients with Crohn’s disease: value of T2- versus T1-weighted gadolinium- enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238:517–530PubMedCrossRef
14.
go back to reference Meyers MA, McGuire PV (1995) Spiral CT demonstration of hypervascularity in Crohn’s disease: “vascular jejunization of the ileum” of the “comb sign”. Abdom Imaging 20:327–332PubMedCrossRef Meyers MA, McGuire PV (1995) Spiral CT demonstration of hypervascularity in Crohn’s disease: “vascular jejunization of the ileum” of the “comb sign”. Abdom Imaging 20:327–332PubMedCrossRef
15.
go back to reference Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 14:1017–1024PubMedCrossRef Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 14:1017–1024PubMedCrossRef
16.
go back to reference Chiorean MV, Sandrasegaran K, Saxena R et al (2007) Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterology 102:2541–2550CrossRef Chiorean MV, Sandrasegaran K, Saxena R et al (2007) Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterology 102:2541–2550CrossRef
17.
go back to reference Maselli G, Vecchioli A, Gualdi GF (2006) Crohn disease of the small bowel: MR enteroclysis versus conventional enteroclysis. Abdom Imaging 31:400–409CrossRef Maselli G, Vecchioli A, Gualdi GF (2006) Crohn disease of the small bowel: MR enteroclysis versus conventional enteroclysis. Abdom Imaging 31:400–409CrossRef
18.
go back to reference Wiarda BM, Kuipers EJ, Heitbrink MA, van Oijen SA, Stoker J (2006) MR enteroclysis of inflammatory small-bowel diseases. AJR Am J Roentgenol 187:522–531PubMedCrossRef Wiarda BM, Kuipers EJ, Heitbrink MA, van Oijen SA, Stoker J (2006) MR enteroclysis of inflammatory small-bowel diseases. AJR Am J Roentgenol 187:522–531PubMedCrossRef
19.
go back to reference Paulsen SR, Huprich JE, Fletscher JG et al (2006) CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 26:641–657PubMedCrossRef Paulsen SR, Huprich JE, Fletscher JG et al (2006) CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 26:641–657PubMedCrossRef
20.
go back to reference Sailer J, Peloschek P, Schober E et al (2005) Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn’s disease. AJR Am J Roentgenol 185:1575–1581PubMedCrossRef Sailer J, Peloschek P, Schober E et al (2005) Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn’s disease. AJR Am J Roentgenol 185:1575–1581PubMedCrossRef
21.
go back to reference Maglinte DD, Siegelsmann EF, Kelvin FM (2000) MR enteroclysis: the future of small-bowel imaging? Radiology 215:639–641PubMed Maglinte DD, Siegelsmann EF, Kelvin FM (2000) MR enteroclysis: the future of small-bowel imaging? Radiology 215:639–641PubMed
22.
go back to reference Maccioni F, Viscido A, Broglia L et al (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228PubMedCrossRef Maccioni F, Viscido A, Broglia L et al (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228PubMedCrossRef
23.
go back to reference Pauls S, Gabelmann A, Schmidt SA, Rieber A et al (2006) Evaluating bowel wall vascularity in Crohn’s disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound. Eur Radiol 16:2410–2417PubMedCrossRef Pauls S, Gabelmann A, Schmidt SA, Rieber A et al (2006) Evaluating bowel wall vascularity in Crohn’s disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound. Eur Radiol 16:2410–2417PubMedCrossRef
24.
go back to reference May A, Nachbar L, Schneider M, Ell C (2005) Double−balloon enteroscopy (push−and−pull enteroscopy) of the small bowel: feasibility, diagnostic and therapeutic yield in patients with suspected small bowel disease. Gastrointest Endoscopy 62:62–70CrossRef May A, Nachbar L, Schneider M, Ell C (2005) Double−balloon enteroscopy (push−and−pull enteroscopy) of the small bowel: feasibility, diagnostic and therapeutic yield in patients with suspected small bowel disease. Gastrointest Endoscopy 62:62–70CrossRef
25.
go back to reference Laghi A, Carbone I, Catalano C et al (2001) Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR Am J Roentgenol 177:1333–1334PubMed Laghi A, Carbone I, Catalano C et al (2001) Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR Am J Roentgenol 177:1333–1334PubMed
26.
go back to reference Patak MA, Froehlich JM, Weymann C, Ritz MA, Zollikofer CL, Wentz KU (2001) Non invasive distension of the small bowel for magnetic resonance imaging. Lancet 258:987–988CrossRef Patak MA, Froehlich JM, Weymann C, Ritz MA, Zollikofer CL, Wentz KU (2001) Non invasive distension of the small bowel for magnetic resonance imaging. Lancet 258:987–988CrossRef
27.
go back to reference Colombel JF, Solem CA, Sandborn WJ et al (2006) Quantitative measurement and visual assessment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity an C reactive protein. Gut 55:1561–1567PubMedCrossRef Colombel JF, Solem CA, Sandborn WJ et al (2006) Quantitative measurement and visual assessment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity an C reactive protein. Gut 55:1561–1567PubMedCrossRef
28.
go back to reference Rieber A, Nüssle K, Reinshagen M, Brambs HJ, Gabelmann A (2002) MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging 27:395–399CrossRef Rieber A, Nüssle K, Reinshagen M, Brambs HJ, Gabelmann A (2002) MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging 27:395–399CrossRef
Metadata
Title
Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy
Authors
Johannes Sailer
Philipp Peloschek
Walter Reinisch
Harald Vogelsang
Karl Turetschek
Wolfgang Schima
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
European Radiology / Issue 11/2008
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-008-1034-6

Other articles of this Issue 11/2008

European Radiology 11/2008 Go to the issue